The filing excerpts provided do not contain sufficient detail about Fate Therapeutics Inc (FATE) to produce a SEC-grounded canonical description. The available text consists only of boilerplate SEC cover page language from the 10-K filed 2026-02-26 (accession 000119312526073699) and does not disclose the company's business activities, revenue model, products, customers, competitors, geographic footprint, or financial results. No supported description can be written from these excerpts alone.

Source: SEC 10-K, filed 2026-02-26

Industry: Biological Products, (No Diagnostic Substances) Peers: BioCryst Pharmaceuticals Inc EQRx, Inc. Immunitybio Inc Prometheus Biosciences, Inc. Relay Therapeutics Inc Sage Therapeutics, Inc. Prokidney Corp Twist Bioscience Corp Verve Therapeutics, Inc.